Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

[EEG, ERP in selective attention paradigm and the level of some metabolites in brain prefrontal cortex].

Lebedeva IS, Semenova NA, Petriaĭkin AV, Agafonov AIu, Mitrofanov AA, Akhadov TA.

Fiziol Cheloveka. 2010 Nov-Dec;36(6):24-31. Russian.

PMID:
21254603
2.

Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition.

Ohrmann P, Kersting A, Suslow T, Lalee-Mentzel J, Donges US, Fiebich M, Arolt V, Heindel W, Pfleiderer B.

Neuroreport. 2004 Mar 1;15(3):549-53.

PMID:
15094521
3.

Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.

Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF.

Psychiatry Res. 2003 Jun 30;123(2):87-100.

PMID:
12850248
4.

Proton magnetic resonance spectroscopy in patients with ischemic stroke.

Federico F, Conte C, Simone IL, Giannini P, Liguori M, Picciola E, Tortorella C, Ferrari E.

Ital J Neurol Sci. 1994 Nov;15(8):413-20.

PMID:
7875959
5.

Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.

Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.

Psychiatry Res. 2004 Jul 30;131(2):95-105.

PMID:
15313516
6.

Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.

Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR.

Biol Psychiatry. 2000 Feb 1;47(3):174-82.

PMID:
10682215
7.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
8.

Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy.

Sibbitt WL Jr, Haseler LJ, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA.

AJNR Am J Neuroradiol. 1994 May;15(5):923-8.

PMID:
8059662
9.

Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder.

Molina V, Sánchez J, Sanz J, Reig S, Benito C, Leal I, Sarramea F, Rebolledo R, Palomo T, Desco M.

Eur Psychiatry. 2007 Nov;22(8):505-12. Epub 2007 Sep 29.

PMID:
17904824
10.
11.

A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania.

Frey BN, Folgierini M, Nicoletti M, Machado-Vieira R, Stanley JA, Soares JC, Kapczinski F.

Hum Psychopharmacol. 2005 Mar;20(2):133-9.

PMID:
15648094
12.

Magnetic resonance spectroscopy of human brain cortex: Relationships between concentrations of some crucial metabolites.

Semenova NA, Varfolomeev SD, Akhadov TA, Lukovenkov AV.

Dokl Biochem Biophys. 2011 Jan-Feb;436:49-52. doi: 10.1134/S1607672911010157. Epub 2011 Mar 4. No abstract available.

PMID:
21369904
13.

Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder.

Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR.

J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S31-8.

PMID:
12880498
14.
15.

Proton spectroscopy of human brain: effects of age and sex.

Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Patterson LJ, Doraiswamy PM, McDonald WM.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Oct;18(6):995-1004.

PMID:
7824764
16.

Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis.

Zabala A, Sánchez-González J, Parellada M, Moreno DM, Reig S, Burdalo MT, Robles O, Desco M, Arango C.

Psychiatry Res. 2007 Oct 15;156(1):33-42. Epub 2007 Aug 31.

PMID:
17764911
17.

Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction.

Houkin K, Kamada K, Kamiyama H, Iwasaki Y, Abe H, Kashiwaba T.

Stroke. 1993 Sep;24(9):1316-21.

18.

Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.

Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.

Arch Gen Psychiatry. 2006 Sep;63(9):969-76.

PMID:
16952999
19.

Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.

Callicott JH, Egan MF, Bertolino A, Mattay VS, Langheim FJ, Frank JA, Weinberger DR.

Biol Psychiatry. 1998 Nov 15;44(10):941-50. Erratum in: Biol Psychiatry 1999 Jan 15;45(2):following 244.

PMID:
9821558
20.

Aging alters the multichemical networking profile of the human brain: an in vivo (1)H-MRS study of young versus middle-aged subjects.

Grachev ID, Swarnkar A, Szeverenyi NM, Ramachandran TS, Apkarian AV.

J Neurochem. 2001 Apr;77(1):292-303.

Items per page

Supplemental Content

Write to the Help Desk